Ignite Creation Date:
2024-05-06 @ 1:23 AM
Last Modification Date:
2024-10-26 @ 11:03 AM
Study NCT ID:
NCT01794299
Status:
COMPLETED
Last Update Posted:
2021-04-12
First Post:
2013-02-14
Brief Title:
Safety and Efficacy of Donor T-lymphocytes Depleted ex Vivo of Host Alloreactive T-cells ATIR in Patients With a Hematologic Malignancy Who Received a Hematopoietic Stem Cell Transplantation From a Haploidentical Donor
Sponsor:
Kiadis Pharma
Organization:
Kiadis Pharma
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-03
Start Date Type:
ACTUAL
Primary Completion Date:
2016-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-09
Completion Date Type:
ACTUAL
First Submit Date:
2013-02-14
First Submit QC Date:
February 15 2013
Study First Post Date:
2013-02-18
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2021-01-12
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
2017-08-16
Disp First Submit QC Date:
August 16 2017
Disp First Post Date:
2017-08-18
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2021-03-17
Last Update Post Date:
2021-04-12
Last Update Post Date Type:
ACTUAL